semaglutide for ckd kidney issues with Semaglutides Are Poised to Remake Chronic Disease Care Ozempic and GLP-1 Drugs: Risk – Chronic Kidney Disease | Ozempic®

The mechanisms driving these effects are multifaceted, involving the suppression of neuroinflammation via the TLR4/NF-B pathway and restoration of brain energy metabolism through the activation of the AMPK and SIRT1/GLUT4 signaling cascades (Wang et al., 2023

R.GlynneR

Semaglutide is a GLP-1 receptor agonist with no direct action on renal potassium handling or cellular potassium distribution

While I didnt lose much weight at first, I definitely felt less bloated and had no more gas

share high obesity rates and a "strong uptake" in GLP-1 drugs, the researchers noted in a press release

The lower orforglipron dose of 12 mg produced 6.7 percent weight loss, about 13.7 pounds